Multiple dosing: intravenous bolus administration

Slides:



Advertisements
Similar presentations
First, zero, pseudo-zero order elimination Clearance
Advertisements

Clinical Pharmacokinetics
PHARMACOKINETIC.
SEMINAR ON NONCOMPARTMENTAL PHARMACOKINETICS
Pharmacokinetics as a Tool
Plasmids Chromosome Plasmid Plasmid + Transposon Plasmid + integron Plasmid+transposon +intergron Chromosome Chromosome + transposon Chromosome + transposon.
Pharmacokinetics of Drug Absorption
Pharmacokinetics Questions
Nonlinear pharmacokinetics
1 Intravenous Infusion Equations Some drugs are administered using a continuous intravenous infusion, and if the infusion is discontinued the serum concentration/time.
One-compartment open model: Intravenous bolus administration
Multiple IV Dosing Pharmacokinetic Research, Bioequivalence Studies,
Index of Simulations 1-Compartment, IV bolus 1-Compartment, IV infusion: Steady- State1-Compartment, IV infusion: Steady- State 1-Compartment, IV infusion:
Laplace transformation
Practical Pharmacokinetics
Practical Pharmacokinetics September 11, 2007 Frank F. Vincenzi.
Week 4 - Biopharmaceutics and Pharmacokinetics
Dose Adjustment in Renal and Hepatic Disease
Toxicokinetic Calculations
Dosing Regimen Design Infusion regimen.
Gokaraju Rangaraju College of Pharmacy
INTRAVENOUS INFUSION.
CLEARANCE CONCEPTS Text: Applied Biopharm. & PK
University of Jordan-Faculty of Pharmacy
The General Concepts of Pharmacokinetics and Pharmacodynamics Hartmut Derendorf, PhD University of Florida.
Nonlinear Pharmacokinetics
PLASMA HALF LIFE ( t 1/2 ).  Minimum Effective Concentration (MEC): The plasma drug concentration below which a patient’s response is too small for clinical.
Multiple Dosing: Intermittent or multiple dose regimen
PHARMACOKINETIC MODELS
INJECTAFER Pharmacokinetics (PK) and Pharmacodynamics (PD) Christy S. John, Ph.D Division of Clinical Pharmacology V Office of Clinical Pharmacology Division.
1-Compartment Oral Dosing 400 mg of moxifloxacin is administered orally to Mr BB, a 68 yr old male who weighs 75 kg. Blood samples were drawn following.
Drug Administration Pharmacokinetic Phase (Time course of ADME processes) Absorption Distribution Pharmaceutical Phase Disintegration of the Dosage Form.
One Compartment Open Model IV bolus
Intravenous Infusion Previous rates of administration were instantaneous IV bolus and first order absorption. As a rate (mg/hr) a first order rate constantly.
The General Concepts of Pharmacokinetics and Pharmacodynamics
1 Single-dose kinetics Plasma [Drug] curve Upon administration [drug] plasma reaches a max Then begins to decline as the Drug is eliminated Cp max = max.
CLINICAL PHARMACOKINETICS OF LIDOCAINE
Noncompartmental Models. Introduction The noncompartmental approach for data analysis does not require any specific compartmental model for the system.
Clinical Pharmacokinetics Fundamental hypothesis: a relationship exists between the pharmacological or toxic response to a drug and the accessible concentration.
Continuous intravenous infusion (one-compartment model)
BIOPHARMACEUTICS.
Phoenix WinNonLin Assignment Due Today Access Phoenix remotely.
Clinical Pharmacokinetics of Phenobarbital
Prof. Dr. Henny Lucida, Apt
Design of Sustained Release Dosage Forms
Clinical Pharmacokinetic Equations and Calculations
Lecture 2 Clearance, maintenance dose and AUC
Time Plasma Conc (hr) (mg/L) Below limit of detection 1 Compartment IV Analysis & Renal Elimination 500 mg of tobramycin.
Objectives Compartment Modeling of Drugs Models describing drug concentration-time profiles Multi-compartment Models.
Pharmacokinetic Questions
Pharmacokinetics 3rd Lecture
MULTIPLE DOSAGE REGIMEN
Allie punke Pharmacokinetics tutoring Fall 2016
Allie punke Pharmacokinetics tutoring Fall 2016
Allie punke pharmcokinetics Allie punke
The aminoglycoside antibiotics
Pharmacokinetics Tutoring
PHARMACOKINETICS Allie punke
Pharmacokinetics Tutoring
Controlled drug release
Lab-3 practical pharmacology
PHARMACOKINETICS Allie punke
Clinical Pharmacokinetics
School of Pharmacy, University of Nizwa
1 Concentration-time curve
Multiple ORAL Dosing Objectives
REFERENCE: APPLIED CLINICAL Slideshow by: lecturer HADEEL DELMAN
The timing of gentamicin administration affects the concentration-time profile in patients using hemodialysis. The timing of gentamicin administration.
Presentation transcript:

Multiple dosing: intravenous bolus administration Dr Mohammad Issa Saleh

Multiple dosing calculations using Superposition Let: Dose 1  Conc. 1 and: Dose 2  Conc. 2 then the response system behaves according to the superposition principle if: Dose 1 +Dose 2  Conc. 1 + Conc. 2 and in that case the response system is a linear response system 2

Multiple dosing calculations using Superposition A patient is to be given 100 mg of a drug intravenously. Assuming that K = 0.10 hr-1 and a V = 15 L, estimate the following: The half life 3

Multiple dosing calculations using Superposition The concentration 2 hrs after the dose The concentration 10 hrs after the dose 4

Multiple dosing calculations using Superposition The concentration 18 hrs after the dose 5

6

Multiple dosing calculations using Superposition Assuming that 100 mg of the drug is administered every 8 hrs, estimate the concentration 2 hrs after the third dose using the values calculated in parts 2-4. What property of the linear systems did you use to answer this question? 7

Conc. After the first dose 8

Conc. After the second dose 9

Conc. After the third dose 10

Total Conc. 11

t = 2 hrs after third dose = 10 hrs after second dose = 18 hrs after first dose 12

Multiple dosing calculations using Superposition Assuming that 100 mg of the drug is administered every 8 hrs, estimate the concentration 2 hrs after the third dose using the values calculated in parts 2-4. What property of the linear systems did you use to answer this question? 13

Multiple dosing calculations using Superposition The principle of superposition assumes that early doses of drug do not affect the pharmacokinetics of subsequent doses. Therefore, the blood levels after the second, third, or nth dose will overlay or superimpose the blood level attained after the (n – 1)th dose

Multiple administration every 4 hrs Dose Number Time (hr) Dose 1 Dose 2 Dose 3 Dose 4 Total 1   21.0 3 19.8 2 4 16.9 5 14.3 35.3 7 10.1 29.9 8 8.50 25.4 9 7.15 42.5 11 5.06 35.0 12 4.25 29.7 13 3.58 46.0 15 2.53 37.5

Multiple IV bolus administration Concentration after n doses: where r: n: number of doses, T: dosing interval

Multiple IV bolus administration Concentration at steady state: where R is the accumulation ratio: T: dosing interval

Multiple IV bolus administration: useful equations Maximum concentration after n doses: Maximum concentration at steady state:

Multiple IV bolus administration: useful equations Minimum concentration after n doses: Minimum concentration at steady state:

Conc time profile:

The AUC during a dosing interval at steady state is equal to the total AUC following a single dose (For linear PK)

Multiple IV bolus administration: useful equations Average concentration at steady state: As explained in the previous slide, AUC for a single dose is:

Predicting average Css using single dose data

Time to reach steady state conc. The time required to reach to a certain fraction of the steady-state level is given by: Time required to achieve steady-state depends on the half-life and is independent of the rate of dosing and the clearance To get to 95% of the steady-state: 5 half-lives are needed To get to 99% of the steady-state: 7 half-lives are needed

Different doses regimen have the same average steady state conc: The same dosing rate (Dose/ T)

Multiple IV bolus dosing compared to IV infusion

Multiple IV bolus dosing compared to IV infusion For IV infusion: For multiple IV bolus (dosing rate = dose/ dosing interval): The steady-concentration depends on the rate of dosing and the clearance

Example 1 To a patient 250 mg penicillin with t½ of 1 h and Vd of 25 L is administered every 6 h intravenously Estimate Cmax, Cmin and Cav at steady state Has the objective of maintaining concentration above minimum inhibitory concentration (4 mg/L) been achieved in this therapy? Elaborate! How long did it take to reach 95% of Css? Is the idea of giving a bolus dose to achieve Css in a shorter time feasible with regard to this drug?

Example 1

Example 1 Drug concentration cannot be maintained above the MIC if it is being administered every 6 h (6 x t½). Because almost 98% of the dose is out of the body at the time of the next administration. However, conventionally penicillins are given q.i.d. and it is known that they are effective. Therefore, there is no need for keeping the concentration above MIC during the entire therapy.  4.3 hrs are needed to get to 95% of Css (i.e. Css was obtained as a result of the first dose)

Example 1 The steady-state is achieved very rapidly (after the first dose). Since there is no need for accumulation, there is little justification for giving a loading dose.

Example 2 A patient is receiving 1000 mg of sulfamethoxazole iv every 12 hours for the treatment of severe gram-negative infection. At steady state the maximum and minimum serum sulfamethoxazole concentrations were 81.5 mg/L and 40 mg/L, respectively. Estimate the values of K and VD

Example 2